Global Psoriasis Market DataPack - Focus on Plaque Psoriasis (2016-2020)
The Industry DataPack provides a unique mix of market information, analysis and projections based on quantitative and qualitative research.
The DataPack provides quantitative analysis of the current market and estimations from 2016 to 2020.
The current market figures and future estimations are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
The DataPack provides quantitative analysis of the current market and estimations from 2016 to 2020.
The current market figures and future estimations are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
Current Treatment Options for Psoriasis
Global Psoriasis Market by Value (2013-2017E)
Global Psoriasis Market by Therapy (2015)
Global Psoriasis Market by Therapy (2025E)
The US Autoimmune Disease Market by Value (2010-2015)
The US Psoriasis Prevalence (2016E-2020E)
The US Psoriasis Market by Value (2010-2015)
The US Psoriasis Market Forecast by Value (2016E-2020E)
The US Psoriasis Market by Treatment (2015)
The US Psoriasis Market by IL Inhibitors (2016E-2020E)
The US Plaque Psoriasis Prevalence (2016E-2020E)
The US Plaque Psoriasis Patients On Treatment (2016E-2020E)
The US Plaque Psoriasis Biologics Market by Type (2015)
Global Cigarette Consumption (1910-2014)
Global Spending on Medicines (2010-2020E)
Global Per Capita Healthcare Expenditure (2006-2015E)
Global Sales of Prescription Drugs (2010-2015E)
The US Annual Revenue Per Patient for Psoriasis Drugs (2015)
Johnson and Johnson’s Revenue Share by Segment (2015)
Johnson and Johnson’s Revenue and Net Income (2011-2015)
Abbvie’s Revenue Share by Products (2015)
Abbvie Revenue and Net Income (2011-2015)
Abbvie’s Research & Development Expenditure (2013-2015)
Amgen’s Revenue Share by Products (2015)
Amgen Inc. Revenue and Net Income (2012-2015)
Amgen’s R&D Expenditure (2012-2015)
Novartis Revenue Share by Segments (2015)
Novartis Revenue and Net Income (2012-2015)
Status of New Drugs against Psoriasis
Key Pipeline Products in Conventional Therapies (2015)
Key IL-Based Treatments in Development
Major Side Effects of New Psoriasis Drugs
Price Comparison of Key Biologics (2015)
Biologics Treatment by Revenue (2015)
J&J Research and Development Expenditure by Segments (2014-2015)
Global Psoriasis Market by Value (2013-2017E)
Global Psoriasis Market by Therapy (2015)
Global Psoriasis Market by Therapy (2025E)
The US Autoimmune Disease Market by Value (2010-2015)
The US Psoriasis Prevalence (2016E-2020E)
The US Psoriasis Market by Value (2010-2015)
The US Psoriasis Market Forecast by Value (2016E-2020E)
The US Psoriasis Market by Treatment (2015)
The US Psoriasis Market by IL Inhibitors (2016E-2020E)
The US Plaque Psoriasis Prevalence (2016E-2020E)
The US Plaque Psoriasis Patients On Treatment (2016E-2020E)
The US Plaque Psoriasis Biologics Market by Type (2015)
Global Cigarette Consumption (1910-2014)
Global Spending on Medicines (2010-2020E)
Global Per Capita Healthcare Expenditure (2006-2015E)
Global Sales of Prescription Drugs (2010-2015E)
The US Annual Revenue Per Patient for Psoriasis Drugs (2015)
Johnson and Johnson’s Revenue Share by Segment (2015)
Johnson and Johnson’s Revenue and Net Income (2011-2015)
Abbvie’s Revenue Share by Products (2015)
Abbvie Revenue and Net Income (2011-2015)
Abbvie’s Research & Development Expenditure (2013-2015)
Amgen’s Revenue Share by Products (2015)
Amgen Inc. Revenue and Net Income (2012-2015)
Amgen’s R&D Expenditure (2012-2015)
Novartis Revenue Share by Segments (2015)
Novartis Revenue and Net Income (2012-2015)
Status of New Drugs against Psoriasis
Key Pipeline Products in Conventional Therapies (2015)
Key IL-Based Treatments in Development
Major Side Effects of New Psoriasis Drugs
Price Comparison of Key Biologics (2015)
Biologics Treatment by Revenue (2015)
J&J Research and Development Expenditure by Segments (2014-2015)
